Healthcare - Biotechnology - NASDAQ - US
$ 3.16
-12.2 %
$ 206 M
Market Cap
-8.1
P/E
CASH FLOW STATEMENT
-15.1 M
OPERATING CASH FLOW
-8 M
INVESTING CASH FLOW
121 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Zura Bio Limited
| Net Income | -60.6 M |
| Depreciation & Amortization | 168 K |
| Capital Expenditures | -8 M |
| Stock-Based Compensation | 9.66 M |
| Change in Working Capital | 5.12 M |
| Others | 29.9 M |
| Free Cash Flow | -23.1 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | |
|---|---|---|---|
| OPERATING CASH FLOW | |||
| Net Income | (60.6) | 3.5 | 8.4 |
| Depreciation & Amortization | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock Based Compensation | 9.7 | 0.3 | 0 |
| Other Operating Activities | 30.7 | (6.6) | (9.3) |
| Change in Working Capital | 5.1 | 1.6 | (0.2) |
| Cash From Operations | (15.1) | (1.1) | (1.1) |
| INVESTING CASH FLOW | |||
| Capital Expenditures | (8.0) | (12.0) | 0 |
| Other Items | 0 | 0 | (139.4) |
| Cash From Investing Activities | (8.0) | (12.0) | (139.4) |
| FINANCING CASH FLOW | |||
| Common Stock Repurchased | 0 | 0 | 0 |
| Total Debt Repaid | (10.0) | 7.6 | (0.1) |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 14.9 | 7.2 | 0.5 |
| Cash From Financing Activities | 121.3 | 0.4 | 141.2 |
| CHANGE IN CASH | |||
| Net Change In Cash | 98.2 | (0.7) | 0.7 |
| FREE CASH FLOW | |||
| Free Cash Flow | (23.1) | (13.1) | (1.1) |